Jenny Griffith - Health Economics and Outcomes Research, AbbVie Inc

Brian G. Feagan,Remo Panaccione,Stefan Schreiber, Edward V. Loftus, Laurent Peyrin-Biroulet, Takehiro Arai, Wan-Ju Lee,Jenny Griffith,Jasmina Kalabic, Kristina Kligys,Si Xuan, Xiaomei Liao,Marc Ferrante

Gastro Hep Advancespp.100603, (2024)

Cited0Views0Bibtex

S5 Sustained Improvements in Health-Related Quality of Life Outcomes with Long-Term Risankizumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the FORTIFY Open-Label, Long-Term Extension

Edward V. Loftus, Laurent Peyrin-Biroulet,Subrata Ghosh, Namita Joshi, Nidhi Shukla,Jenny Griffith,Alexandra Song,Brooke Kim, Andrew Platt,Edouard Louis

American Journal of Gastroenterologyno. 12S (2024)

Cited0Views0Bibtex

IMPROVEMENT IN INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE ITEMS FATIGUE, DEPRESSION, ANXIETY, AND BOWEL URGENCY IN PATIENTS WITH CROHN'S DISEASE TREATED WITH UPADACITINIB IN PHASE 3 TRIALS

Edward V. Loftus,David T. Rubin,Edouard Louis,Astrid Rausch, Luc Biedermann, Namita Joshi,Ana P. Lacerda,Jenny Griffith,Kristina Kligys,Samuel Anyanwu, Nidhi Shukla,Peter Bossuyt

GASTROENTEROLOGYno. 5 (2024): S849-S849

Cited0Views0Bibtex

Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated with Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies

Jean-Frederic Colombel,Stefan Schreiber,Geert D'Haens,Joanne Rizzo,Kristina Kligys,Jenny Griffith,Javier Zambrano,Qian Zhou,Yafei Zhang,Jasmina Kalabic,Florian Rieder,Marla C. Dubinsky,Remo Panaccione

JOURNAL OF CROHNS & COLITISno. 6 (2024): 818-827

Cited0Views0WOSBibtex

Evaluating the Time Needed to Access Advanced Therapies for Crohn's Disease and Ulcerative Colitis

Casey Chapman,Bincy P. Abraham,Parakkal Deepak, Tianzhou Yu,Jenny Griffith,Si Xuan,Brooke Kim, Cecile Holweg, Jae Rok Kim,Corey A. Siegel

AMERICAN JOURNAL OF GASTROENTEROLOGY（2024）

Cited0Views0Bibtex

Tu1095 RISANKIZUMAB IS ASSOCIATED WITH LOWER COST PER RESPONDER AND COST PER REMITTER VERSUS USTEKINUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: ECONOMIC ANALYSES FROM THE SEQUENCE TRIAL

Ryan C. Ungaro,Raymond K. Cross, Jessica R. Allegretti,Jenny Griffith,Ezequiel Neimark, Rob Pearson, Tianzhou Yu

Gastroenterologyno. 5 (2024): S-1235

Cited0Views0Bibtex

Su1863 IMPROVEMENT IN INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE ITEMS FATIGUE, DEPRESSION, ANXIETY, AND BOWEL URGENCY IN PATIENTS WITH CROHN'S DISEASE TREATED WITH UPADACITINIB IN PHASE 3 TRIALS

Edward V. Loftus,David T. Rubin,Edouard Louis,Astrid Rausch,Luc Biedermann,Namita Joshi,Ana P. Lacerda,Jenny Griffith,Kristina Kligys,Samuel Anyanwu, Nidhi Shukla,Peter Bossuyt

Gastroenterologyno. 5 (2024): S-849

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn